Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15090414.
- Also identified by PMC identifier 1772138.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To study the effect of axial length on the hypotensive effect of latanoprost in primary open angle glaucoma (POAG) in a prospective, observational study. The authors measured axial length and baseline intraocular pressure (IOP) of 109 eyes with POAG, and then repeated the IOP measurements at 1, 3, and 6 months after starting treatment with latanoprost. The mean IOP level was significantly lower in eyes with a shorter axial length compared with the eyes with a longer axial length both at 3 and 6 months of treatment (p = 0.03 and p = 0.04, respectively, ANOVA). The hypotensive effect resulting from treatment with latanoprost could be related to ocular axial length.
Medical subject headings
- Antihypertensive Agents
- Eye
- Glaucoma, Open-Angle
- Prostaglandins F, Synthetic